Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteinase Activated Receptor 1 (PAR-1) is a G protein-coupled receptor activated by proteolytic cleavage, primarily by thrombin. It plays a crucial role in hemostasis, thrombosis, vascular biology, inflammation, and cancer progression. Activation leads to downstream signaling pathways that influence platelet aggregation, vascular permeability, cytokine production, and tumor cell proliferation. Therapeutic strategies focus on inhibiting PAR-1 signaling to treat thrombosis and certain cancers.
Inhibition of PAR-1 signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteinase Activated Receptor 1 (PAR-1).